As biological products move towards clinical and commercial stages, their analytical requirements become increasingly complex. From method development and characterization to quality control and regulatory requirements, analytical testing plays a critical role in demonstrating product quality, safety, and consistency.
Strategic use of analytical outsourcing can provide access to specialized expertise and qualified laboratory capabilities, while allowing development teams to focus on their core activities. Selecting the right partner and defining a fit-for-purpose analytical strategy are key to reducing risk and supporting efficient development.
In this webinar, Leo Groenewegen, CEO of Nordic BioAnalysis AB, will discuss how companies can use analytical outsourcing strategically, what to consider when selecting accredited and GMP-compliant laboratory partners, and how fit-for-purpose analytics can reduce risk, strengthen regulatory readiness and accelerate development.
Whether you work in biologics development, quality, CMC, or innovation support, this session offers practical perspectives on an important part of the journey from innovation to patient.
Sign up: LINK
